Go to Header
Go to Navigation
Go to Content
Go to Footer
Login
Help
中文（繁體）
Research Resources
CUHK UPDates
Theses
Experts List
User Guides
About Us
List of Researchers
> Assistant Professor Xiang ZHANG
Home
Research Outputs
Researcher Profiles
Department Profiles
Research Areas
Professor ZHANG Xiang
Personal Information
Position and Department
Assistant Professor
,
Department of Medicine and Therapeutics
Phone
852-37636102
Email
b135073@cuhk.edu.hk
ORCiD
0000-0002-3222-5824
CUHK Research Outputs
1 of 2
Bile acids, gut microbiota, and therapeutic insights in hepatocellular carcinoma
(
2024
)
Gut mycobiome in metabolic diseases: mechanisms and clinical implication
(
2024
)
Spatial proteomics of immune microenvironment in nonalcoholic steatohepatitis-associated hepatocellular carcinoma
(
2024
)
Targeting squalene epoxidase restores anti-PD-1 efficacy in metabolic dysfunction-associated steatohepatitis-induced hepatocellular carcinoma
(
2024
)
Altered gut microbiome composition by appendectomy contributes to colorectal cancer
(
2023
)
Bifidobacterium pseudolongum-generated acetate suppresses non-alcoholic fatty liver disease-associated hepatocellular carcinoma
(
2023
)
Excess body weight: Novel insights into its roles in obesity comorbidities
(
2023
)
Inhibition of CEMIP Potentiates the Effect of Sorafenib on Metastatic Hepatocellular Carcinoma by Reducing the Stiffness of Lung Metastases
(
2023
)
Lactobacillus gallinarum-derived metabolites boost anti-PD1 efficacy in colorectal cancer by inhibiting regulatory T cells through modulating IDO1/Kyn/AHR axis
(
2023
)
METTL3 drives NAFLD-related hepatocellular carcinoma and is a therapeutic target for boosting immunotherapy
(
2023
)
Parabacteroides distasonis uses dietary inulin to suppress NASH via its metabolite pentadecanoic acid
(
2023
)
SERPINA12 promotes the tumorigenic capacity of HCC stem cells through hyperactivation of AKT/β-catenin signaling
(
2023
)
Sonazoid contrast-enhanced ultrasonography for the diagnosis of hepatocellular carcinoma: strengths and shortcomings
(
2023
)
Targeting of SLC25A22 boosts the immunotherapeutic response in KRAS-mutant colorectal cancer
(
2023
)
TUBB4B is a novel therapeutic target in non-alcoholic fatty liver disease-associated hepatocellular carcinoma
(
2023
)
Vive la resistant starch: A potential treatment for metabolic dysfunction-associated steatohepatitis
(
2023
)
Activated natural killer cell promotes nonalcoholic steatohepatitis through mediating JAK/STAT pathway
(
2022
)
Bifidobacterium Pseudolongum and its Generated Acetate Suppress Non-alcoholic Fatty Liver Disease-associated Hepatocellular Carcinoma
(
2022
)
Diet and gut microbiome in fatty liver and its associated liver cancer
(
2022
)
Emerging insights on immunotherapy in liver cancer
(
2022
)
Gut microbiome modulates host transcription in dietary cholesterol-induced fatty liver-associated liver cancer
(
2022
)
Integrative metabolomic characterisation identifies altered portal vein serum metabolome contributing to human hepatocellular carcinoma
(
2022
)
M1型巨噬细胞促进非酒精性脂肪性肝炎 (M1 macrophages promote non-alcoholic steatohepatitis)
(
2022
)
Mouse Models for Application in Colorectal Cancer: Understanding the Pathogenesis and Relevance to the Human Condition
(
2022
)
Parvimonas micra promotes colorectal tumorigenesis and is associated with prognosis of colorectal cancer patients
(
2022
)
Pien Tze Huang Protects Against Non-Alcoholic Steatohepatitis by Modulating the Gut Microbiota and Metabolites in Mice
(
2022
)
RNA N6-methyladenosine methyltransferase METTL3 drives non-alcoholic fatty liver disease associated hepatocellular carcinoma (NAFLD-HCC) and is a therapeutic target for combination immunotherapy
(
2022
)
Squalene epoxidase drives cancer cell proliferation and promotes gut dysbiosis to accelerate colorectal carcinogenesis
(
2022
)
Streptococcus anginosus promotes gastric carcinogenesis in conventional and germ-free mice
(
2022
)
The Gut–liver Axis in Immune Remodeling of Hepatic Cirrhosis
(
2022
)
The role of gut–liver axis in gut microbiome dysbiosis associated NAFLD and NAFLD-HCC
(
2022
)
Activated natural killer cell promotes non-alcoholic steatohepatitis through releasing pro-inflammatory cytokines
(
2021
)
Complement component C3: a novel biomarker participating in the pathogenesis of Non-alcoholic fatty liver disease
(
2021
)
Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites
(
2021
)
Dietary inulin ameliorates non-alcoholic steatohepatitis through direct modulating gut microbiota and metabolites
(
2021
)
Microbial community heterogeneity within colorectal neoplasia and its correlation with colorectal carcinogenesis
(
2021
)
TUBB4B was identified as novel therapeutic target of nonalcoholic fatty liver disease associated-hepatocellular carcinoma
(
2021
)
Microtubule associated protein 9 inhibits liver tumorigenesis by suppressing ERCC3
(
2020
)
Bone marrow-derived macrophage contributes to fibrosing steatohepatitis through activating hepatic stellate cells
(
2019
)
Dietary cholesterol drives spontaneous fatty liver-associated liver cancer associated with mitochondrial dysfunction
(
2019
)
Docking protein-1 promotes inflammatory macrophage signaling in gastric cancer
(
2019
)
Macrophage p38α promotes nutritional steatohepatitis through M1 polarization
(
2019
)
Macrophage p38α promotes nutritional steatohepatitis through M1 polarization
(
2019
)
New insights and therapeutic implication of gut microbiota in non-alcoholic fatty liver disease and its associated liver cancer
(
2019
)
The phytochemical polydatin ameliorates non-alcoholic steatohepatitis by restoring lysosomal function and autophagic flux.
(
2019
)
Defective lysosomal clearance of autophagosomes and its clinical implications in nonalcoholic steatohepatitis
(
2018
)
NAFLD Related-HCC: The Relationship with Metabolic Disorders
(
2018
)
Animal models of non-alcoholic fatty liver disease: current perspectives and recent advances.
(
2017
)
C-X-C Motif Chemokine 10 Impairs Autophagy and Autolysosome Formation in Non-alcoholic Steatohepatitis
(
2017
)
Gavage of Fecal Samples from Patients with Colorectal Cancer Promotes Intestinal Carcinogenesis in Germ-Free and Conventional Mice
(
2017
)
Most Relevant Area
Gastroenterology and related surgery
(
Internal medicine related
)
Share Link
Last updated on 2024-03-09 at 16:08
Share Link
Your name*
Your email*
Recipient's name*
Recipient's email*
Message
Auxilliary Information
No information will be stored or shared with any third party.
Cancel
Our policy towards the use of cookies
All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Ok to Continue
Cookie Policy
